Literature DB >> 4071380

Early detection of glaucomatous damage. II. Changes in the appearance of the optic disk.

H A Quigley.   

Abstract

Once we understand that an increase in the size of the optic disk cup is due to loss of optic nerve fibers combined with some physical tissue rearrangements, it is quite clear that cupping begins as soon as nerve loss begins. Methods to detect cupping are more sensitive to the earliest glaucoma damage than are present field testing methods. This conclusion is supported by large clinical studies and histological demonstration of nerve fiber loss prior to field loss in eyes with abnormal cups, asymmetric cupping, or nerve fiber layer abnormalities. While automated perimetry is likely to increase the sensitivity of detection, better test methodologies are needed to combine with the objectivity of computer-assisted machines. Disk hemorrhages, nerve fiber layer defects, and color vision abnormalities are early signs of damage, supporting the conclusion that damage is present before field loss. A number of other methods await further testing to determine their effectiveness. The idea that the disease glaucoma is defined by a certain visual field finding on the Goldmann perimeter is not valid if we define glaucoma as an eye with a history of elevated IOP and optic nerve damage. While such field loss is a convenient means of defining a particular stage of damage in glaucoma, there are clearly earlier stages of damage, whether we can always detect them or not. No patient should be told that he or she does not have glaucoma, but rather has ocular hypertension, based on a particular visual field finding. As testing and examination methods improve, so, hopefully, will our ability to determine whether damage is present. As this occurs, we will be better enabled to select most rationally those patients who will benefit from therapy. The idea that field testing is relatively insensitive to the earliest glaucoma damage might lead the skeptic to conclude that perimetry is not worth the trouble. This review has indicated that none of our present methods, ophthalmoscopic, psychophysical or otherwise, is perfect. But to omit using any of them (especially field testing) does a great disservice to the glaucoma patient. The greatest usefulness of the new automated instruments is that adequate field testing is now available in a cost-effective form to every ophthalmic office. We need to strive for better detection and follow-up of glaucoma damage to prevent needless blindness.

Entities:  

Mesh:

Year:  1985        PMID: 4071380     DOI: 10.1016/0039-6257(85)90080-3

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  8 in total

1.  Clinical detection of early glaucomatous foveal involvement.

Authors:  C Capoferri; A Garavaglia; M Buscemi; R Brancato
Journal:  Int Ophthalmol       Date:  1989-07       Impact factor: 2.031

2.  Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT.

Authors:  Li Guo; Eduardo M Normando; Shereen Nizari; David Lara; M Francesca Cordeiro
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-04       Impact factor: 4.799

3.  Pilot study of the multifocal electroretinogram in ocular hypertension.

Authors:  H H Chan; B Brown
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

4.  Comparison of disc damage likelihood scale, cup to disc ratio, and Heidelberg retina tomograph in the diagnosis of glaucoma.

Authors:  H V Danesh-Meyer; B J Gaskin; T Jayusundera; M Donaldson; G D Gamble
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

5.  Differentiating glaucomatous from non-glaucomatous optic nerve cupping by optical coherence tomography.

Authors:  Preeya K Gupta; Sanjay Asrani; Sharon F Freedman; Mays El-Dairi; M Tariq Bhatti
Journal:  Open Neurol J       Date:  2011-01-26

6.  Mutations in zebrafish lrp2 result in adult-onset ocular pathogenesis that models myopia and other risk factors for glaucoma.

Authors:  Kerry N Veth; Jason R Willer; Ross F Collery; Matthew P Gray; Gregory B Willer; Daniel S Wagner; Mary C Mullins; Ava J Udvadia; Richard S Smith; Simon W M John; Ronald G Gregg; Brian A Link
Journal:  PLoS Genet       Date:  2011-02-17       Impact factor: 5.917

7.  Diagnostic Capability of 3D Peripapillary Retinal Volume for Glaucoma Using Optical Coherence Tomography Customized Software.

Authors:  Yingna Liu; Firas Jassim; Boy Braaf; Ziad Khoueir; Linda Yi-Chieh Poon; Geulah S Ben-David; Georgia Papadogeorgou; Edem Tsikata; Huseyin Simavli; Christian Que; Ramon Lee; Eric Shieh; Benjamin J Vakoc; Brett E Bouma; Johannes F de Boer; Teresa C Chen
Journal:  J Glaucoma       Date:  2019-08       Impact factor: 2.503

8.  Confocal scanning laser ophthalmoscopy classifiers and stereophotograph evaluation for prediction of visual field abnormalities in glaucoma-suspect eyes.

Authors:  Christopher Bowd; Linda M Zangwill; Felipe A Medeiros; Jiucang Hao; Kwokleung Chan; Te-Won Lee; Terrence J Sejnowski; Michael H Goldbaum; Pamela A Sample; Jonathan G Crowston; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-07       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.